Business Context and Reporting Period
This Form 8-K Current Report was filed by Cherry Hill Mortgage Investment Corporation on March 29, 2017. The filing reports the entry into a material definitive agreement regarding an underwritten public offering of common stock.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The primary financial event reported is the issuance of equity:
- Base Offering: 4,500,000 shares of common stock ($0.01 par value).
- Option Exercise: Underwriters exercised a 30-day option to purchase an additional 650,000 shares in full on March 27, 2017.
- Total Shares Issued: 5,150,000 shares.
- Offering Price: The filing text does not provide a clear value for the price per share or total gross proceeds.
Material Changes
The material change reported is the completion of a capital raise through the sale of 5,150,000 shares of common stock. The offering closed on March 29, 2017, pursuant to an effective registration statement on Form S-3. This transaction increases the company's outstanding share count and equity capital, though specific pre- and post-offering balance sheet impacts are not detailed in this text.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or specific risk factors beyond the standard legal disclosures associated with the underwriting agreement. The agreement includes customary representations, warranties, and indemnification provisions where the Company agreed to indemnify the underwriters against certain liabilities. Legal opinions regarding the legality of the shares and tax matters were provided by Venable LLP and Vinson & Elkins L.L.P., respectively.
Investor Verification Checklist
- Verify the offering price per share and total gross proceeds in the associated Prospectus Supplement dated March 23, 2017.
- Confirm the net proceeds to the company after deducting underwriting discounts and commissions.
- Review the updated number of outstanding shares and the impact on earnings per share (EPS) dilution.
- Examine the specific use of proceeds disclosed in the prospectus supplement.